Testing JKN2401 injection for COPD
Part of Lungs & breathing clinical trials.
This trial tests an experimental injection called JKN2401 for people with COPD. It aims to see if it helps reduce flare-ups and improve breathing compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of COPD from a doctor.
- You have a history of smoking or exposure to biomass smoke (like from cooking fires).
- You are already on a stable COPD treatment plan prescribed by your doctor.
- You have had a certain number of COPD flare-ups and have a certain level of breathing difficulty.
- You do not have asthma, other major lung disease, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called 9MW1911 to see if it can help people with moderate to severe COPD who have had recent flare-ups. It is for current or former smokers ages 40 to 75 who are already on standard COPD treatments.
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
This trial is testing a new drug called PRA-216 for people with COPD to see if it is safe and how it affects certain markers in the body. It may be an option if you have stable COPD and are on regular medications.
This study tests an experimental drug called JKN2403 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve breathing compared to a placebo (a dummy pill).
This study tests a new injection called XKH001 to see if it helps people with COPD (chronic lung disease) who have frequent flare-ups despite using regular inhaler medications. The goal is to reduce how often flare-ups happen and improve breathing.
This trial tests an injection called RC1416 for people with moderate-to-severe COPD who still have flare-ups despite using triple inhaler therapy. It may help reduce those flare-ups and improve breathing.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.